FDA 483 - NuCare Pharmaceuticals Inc - January 10, 2020

NuCare Pharmaceuticals Inc in Orange, CA, was cited for issues related to drug product stability and expiration dating during repackaging operations. The firm failed to conduct stability studies for drug products repackaged without desiccants, yet assigned them the original expiration dates. This raises concerns about the quality and purity of the products over time.